RSS-Feed abonnieren

DOI: 10.1055/s-0044-1788542
Quality of Life before and after Radiotherapy in Head and Neck Squamous Cell Cancer Patients Measured Using an Updated Head-Neck Specific EORTC QLQ-H&N43 at a Rural Tertiary Cancer Care Center
Autor*innen
Abstract
Background
Quality of life (QOL) in head and neck squamous cell cancer (HNSCC) patients from rural area is sparsely studied. Aim of this study was to evaluate the QOL before (pre-) and at first follow-up after radiotherapy (RT) (post-RT) in patients of HNSCC at a rural tertiary cancer care center (RTCCC).
Materials and Methods
This analytical study commenced after an institutional ethics committee approval included HSCCC patients registered at a RTCCC from June 2019 to January 2022. Marathi version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ), EORTC QLQ-C30 (v3.0), and an updated head-neck specific EORTC QLQ-H&N43 were served to the eligible patients pre- and post-RT. Clinicodemographic details were collected from prospectively maintained hospital records. Graph-Pad, Instat-3 (California Inc) was used for statistical analysis. Effect size and minimal important change were noted.
Results
A total of 100 patients completed both the pre- and post-RT (6–18 weeks post-RT) QLQ. Median age was 53 years (range: 30–78 years) and man to woman gender ratio was 4.56:1. Majority of the patients were farmer (46%), tobacco users (92%), and from middle socioeconomic class (57%). Oral cavity was the most common subsite involved (62%) and majority presented in locally advanced stage (82%) of disease.
Global health status improved significantly after treatment with a large effect size (ES = –0.84). QOL was significantly improved after treatment except for parameters depicting treatment-related toxicities, that is, dryness of mouth and sticky saliva (ES = –1.75), problem with senses (ES = –1.31), and skin (ES = –1.38).
Coronavirus disease pandemic and limitations of QLQ were few shortcomings of this study.
Conclusion
There is considerable improvement in QOL in HNSCC patients post-RT except for the treatment-related toxicity domains.
Keywords
quality of life - head and neck squamous cell cancer - radiotherapy - rural cancer care center - before and after radiotherapyAuthors' Contributions
C.M.W. contributed to Conception and design, data collection whereas C.M.W., H.J.P. helped in Drafting the manuscript. C.M.W., H.J.P., B.R. completed Analysis and interpretation, revising, approval.
Publikationsverlauf
Eingereicht: 11. Dezember 2023
Angenommen: 26. Juni 2024
Artikel online veröffentlicht:
12. Juli 2024
© 2024. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Coelho KR. Challenges of the oral cancer burden in India. J Cancer Epidemiol 2012; 2012: 701932
- 2 Kim JD, Firouzbakht A, Ruan JY. et al. Urban and rural differences in outcomes of head and neck cancer. Laryngoscope 2018; 128 (04) 852-858
- 3 Clarke JA, Despotis AM, Ramirez RJ, Zevallos JP, Mazul AL. Head and neck cancer survival disparities by race and rural-urban context. Cancer Epidemiol Biomarkers Prev 2020; 29 (10) 1955-1961
- 4 Kulkarni MR. Head and neck cancer burden in India. Int J Head Neck Surg 2013; 4: 29-35
- 5 Rural population in India. Assessed May 2, 2023 at: https://data.worldbank.org/indicator/SP.RUR.TOTL.ZS?locations=IN
- 6 Pulte D, Brenner H. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist 2010; 15 (09) 994-1001
- 7 Calman KC. Quality of life in cancer patients–an hypothesis. J Med Ethics 1984; 10 (03) 124-127
- 8 Yan B, Yang LM, Hao LP. et al. Determinants of quality of life for breast cancer patients in Shanghai, China. PLoS One 2016; 11 (04) e0153714
- 9 Waghmare CM. Why is the EORTC QLQ-C30 (version 3) still the most widely used quality of life assessment tool in oncology?. Cancer Res Stat Treat 2022; 5: 376-378
- 10 Chaukar DA, Das AK, Deshpande MS. et al. Quality of life of head and neck cancer patient: validation of the European organization for research and treatment of cancer QLQ-C30 and European organization for research and treatment of cancer QLQ-H&N 35 in Indian patients. Indian J Cancer 2005; 42 (04) 178-184
- 11 Baile WF, Gibertini M, Scott L, Endicott J. Depression and tumor stage in cancer of the head and neck. Psychooncology 1992; 1: 15-24
- 12 Depta A, Jewczak M, Skura-Madziała A. Quality of life of patients from rural and urban areas in Poland with head and neck cancer treated with radiotherapy. A study of the influence of selected socio-demographic factors. Arch Med Sci 2017; 13 (06) 1474-1482
- 13 Adamowicz JL, Christensen A, Howren MB. et al. Health-related quality of life in head and neck cancer survivors: evaluating the rural disadvantage. J Rural Health 2022; 38 (01) 54-62
- 14 Pateman KA, Cockburn NL, Batstone MD, Ford PJ. Quality of life of head and neck cancer patients in urban and regional areas: an Australian perspective. Aust J Rural Health 2018; 26 (03) 157-164
- 15 Thomas AA, Timmons A, Molcho M. et al. Quality of life in urban and rural settings: a study of head and neck cancer survivors. Oral Oncol 2014; 50 (07) 676-682
- 16 Barot R, Sivabalan T. A study to evaluate the quality of life in head and neck cancer patients admitted in Pravara Rural Hospital, Loni (BK). Asian J Nurs Educ Res 2013; 3: 21-24
- 17 Declaration of Helsinki 2000-WMA-world medical association. Accessed January 21, 2023 at: https://www.wma.net/medical-ethics/doh-oct2000
- 18 Performance scales: Karnofsky and ECOG score. Assessed November 19, 2022 at: https://oncologypro.esmo.org/oncology-in-practice/practice-tools/performance-scales
- 19 Waghmare CM, Pawar HJ, Jain VS, Bhanu A, Thakur PK, Nirmal PH. Marathi translation and linguistic validation of an updated European Organization for Research and Treatment of Cancer Quality of Life module for head and neck. South Asian J Cancer 2020; 9 (04) 199-203
- 20 Scott NW, Fayers PM, Aaronson NK. et al. On behalf of the EORTC quality of life group. EORTC QLQ-30 reference values. Brussels: Published by European Organisation for Research and Treatment of Cancer; 2008: 6
- 21 Part II. Head and Neck. In: Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR. et al., eds. AJCC Cancer Staging Manual. 8th ed.. Chicago, IL: American Joint Commission on Cancer, Springer International Publishing; 2017: 55-161
- 22 Pandey VK, Aggarwal P, Kakkar R. Modified BG Prasads socio-economic classification 2018: The need of an update in present scenario. Indian J Community Health 2018; 30: 82-84
- 23 National Cancer Institute updates CTCAE v5.0. Assessed September 15, 2023 at: http://www.uptodate.com
- 24 Eisenhauer EA, Therasse P, Bogaerts J. et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45 (02) 228-247
- 25 Michael CJ, Machin D. Medical Statistics: A Commonsense Approach. 2nd ed.. West Sussex: John Wiley & Sons Ltd.; 1996: 156
- 26 Karimi AM, Gairola M, Ahlawat P. et al. Health-related quality of life assessment for head-and-neck cancer patients during and at 3 months after radiotherapy - a prospective, analytical questionnaire-based study. Natl J Maxillofac Surg 2019; 10 (02) 134-140
- 27 Musoro JZ, Coens C, Singer S. et al; EORTC Head and Neck and Quality of Life Groups. Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer. Head Neck 2020; 42 (11) 3141-3152
- 28 Singer S, Hammerlid E, Tomaszewska IM. et al; EORTC Quality of Life Group and the EORTC Head and Neck Cancer Group. Methodological approach for determining the minimal important difference and minimal important change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale. Qual Life Res 2022; 31 (03) 841-853
- 29 Mathur P, Sathishkumar K, Chaturvedi M. et al; ICMR-NCDIR-NCRP Investigator Group. Cancer statistics, 2020: report from National Cancer Registry Program, India. JCO Glob Oncol 2020; 6: 1063-1075
- 30 Jimenez JE, Nilsen ML, Gooding WE. et al. Surgical factors associated with patient-reported quality of life outcomes after free flap reconstruction of the oral cavity. Oral Oncol 2021; 123: 105574
- 31 Kelly C, Paleri V, Downs C, Shah R. Deterioration in quality of life and depressive symptoms during radiation therapy for head and neck cancer. Otolaryngol Head Neck Surg 2007; 136 (01) 108-111
- 32 Trotti A, Bellm LA, Epstein JB. et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003; 66 (03) 253-262
- 33 Wijers OB, Levendag PC, Braaksma MMJ, Boonzaaijer M, Visch LL, Schmitz PI. Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors. Head Neck 2002; 24 (08) 737-747
- 34 Mendenhall WM. Mandibular osteoradionecrosis. J Clin Oncol 2004; 22 (24) 4867-4868
- 35 Bhinde SA, Harrington KJ, Nutting CM. Otological toxicity after postoperative radiotherapy for parotide tumors. Clin Oncol 2007; 19: 77-82
- 36 Hammerlid E, Taft C. Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms. Br J Cancer 2001; 84 (02) 149-156
- 37 MacDowell LJ, Rock K, Xu W. et al. Long term late toxicity, quality of life and emotional distress in patients with nasopharyngeal carcinoma treated with IMRT. Int J Radiat Oncol Biol Phys 2018; 102: 340-352
- 38 Rathod S, Gupta T, Ghosh-Laskar S, Murthy V, Budrukkar A, Agarwal J. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study. Oral Oncol 2013; 49 (06) 634-642
- 39 Gupta T, Kannan S, Ghosh-Laskar S, Agarwal JP. Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma. PLoS One 2018; 13: e0200137
- 40 Kotz T, Federman AD, Kao J. et al. Prophylactic swallowing exercises in patients with head and neck cancer undergoing chemoradiation: a randomized trial. Arch Otolaryngol Head Neck Surg 2012; 138 (04) 376-382
- 41 van Gogh CD, Verdonck-de Leeuw IM, Boon-Kamma BA. et al. The efficacy of voice therapy in patients after treatment for early glottic carcinoma. Cancer 2006; 106 (01) 95-105
- 42 Razfar A, Mundi J, Grogan T. et al. Intensity modulated radiotherapy for head and neck cancer: cost implications. Am J Otolaryngol 2016; 37(6): 479-483
- 43 Eisbruch A, Schwartz M, Rasch C. et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 2004; 60 (05) 1425-1439
- 44 Kumar RV, Bhaskar S. Is the fast-paced technological advancement in radiation therapy good for India. J Cancer Policy 2015; 4: 26-30
- 45 Laskar SG, Sinha S, Krishnatry R, Grau C, Mehta M, Agarwal JP. Access to radiation therapy: from local to global and equality to equity. JCO Glob Oncol 2022; 8: e2100358
- 46 Nguyen M-L, Derouen JT, Cantrell JN. et al. Rural disparities in head and neck cancer from 2017 to 2021: a single institution analysis. J Radiother Pract 2023; 22: 1-7
- 47 Mukherjee A, Idigo AJ, Ye Y. et al. Geographical and racial disparities in head and neck cancer diagnosis in South-Eastern United States: using real-world electronic medical records data. Health Equity 2020; 4 (01) 43-51
- 48 Pignon JP, Bourhis J, Domenge C, Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000; 355 (9208) 949-955
- 49 Felce D, Perry J. Quality of life: its definition and measurement. Res Dev Disabil 1995; 16 (01) 51-74
